Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gynofit vs Metronidazole for Bacterial Vaginosis
NCT02042287Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Jun 2014
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Insel Gruppe. Primary endpoint: Proportion of patients with treatment success based on the Amsel criteria at 3 weeks. Started Jun 2014; status: completed.
Beyond the preview
Go deeper on NCT02042287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042287.